|
1) Park SJ, Kim YH, Lee BK, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol. 2005; 45: 351-6
|
|
|
|
2) Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006; 113: 2542-7
|
|
|
|
|
|
3) Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008; 358: 1781-92
|
|
|
|
|
|
4) Valgimigli M, van Mieghem CA, Ong AT, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005; 111: 1383-9
|
|
|
|
|
|
5) Toyofuku M, Kimura T, Morimoto T, et al. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry. Circulation. 2009; 120: 1866-74
|
|
|
|
|
|
6) Seung KB, Park D-W, Kim Y-H. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008; 358: 1781-92
|
|
|
|
|
|
7) Park D-W, Seung KB, Kim Y-H. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol. 2010; 56: 117-24
|
|
|
|
|
|
8) Serruys PW, Morice M-C, Kappetein AP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-72
|
|
|
|
|
|
9) Morice M-C, Serruys P-W. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation. 2010; 121: 2645-53
|
|
|
|
|
|
10) The Bypass Angioplasty Revascuarization Investigation (BARI) Investigators. comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1999; 335: 217-25
|
|
|
|
|
|
11) Serruys PW, Unger F, Sousa JE. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001; 344: 1117-24
|
|
|
|
|
|
12) Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008; 118: 1146-54
|
|
|
|
|
|
13) Serruys PW, Onuma Y, Garg S. 5-Year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010; 55: 1093-101
|
|
|
|
|